NEWS DESK

DYN Stock News, News Score & What It Could Mean

Dyne Therapeutics, Inc. - Common Stock (DYN) is currently showing a neutral headline tone with a mixed / range backdrop. The latest news flow is being framed here as context rather than prediction, so beginners can quickly see whether headlines are helping, hurting, or complicating the chart story. Earnings tone is currently no clear earnings read.

HEADLINE TAKE: The current headline mix looks balanced, so the overall news tone reads neutral right now.
Change stock
Search another ticker to view its latest news page.
OPEN ON TRADINGVIEW ↗TRADE THIS STOCK
Full chart, indicators and drawing tools on TradingView. Move to Platforms when you are ready to act.
NEWS SCORE
50/100
Neutral
Bearish
Neutral
Bullish
Earnings Tone
50
Structured data unavailable
Confidence
Low
Headline depth
Last Price
DATA UNAVAILABLE
Trend Context
Mixed / range
Latest briefing

What's happening with DYN

Stock Titan8 Jul 2026

Dyne Therapeutics (DYN) director-linked Atlas funds sell 777K shares under 10b5-1 plan - Stock Titan

<a href="https://news.google.com/rss/articles/CBMitAFBVV95cUxNTDN5X3AyTXZ1bmxmY2VjVDM2OG5KNHhrRmM0WUtzaFhkcExoRkNwWkozMzRkejN1alg3RjBITVpSWUM0LUZhekR1cVVyc0I1d3Fjd3k0bE1OcjM4Ukk4dXdZRzJmQ1ZKWjAwSDZWcGZGUjltMjdVekZpVjA4aUFVVDZSOGJlUXdZUDNFcGQ0UjFBdU0yc3AyMk54b2MxeUVPVU4xemZhWkxuUXlldFBId2ZVOWM?oc=5" target="_blank">Dyne Therapeutics (DYN) director-linked Atlas funds sell 777K shares under 10b5-1 plan</a>&nbsp;&nbsp;<font color="#6f6f6f">Stock Titan</font>

Article excerpt provided by the FMP news feed. AI is used only for the optional "Why this matters" read.Read full article ↗
Moomoo30 Jun 2026

Dyne Therapeutics(DYN.US) Director Sells US$10.71 Million in Common Stock - Moomoo

<a href="https://news.google.com/rss/articles/CBMiogFBVV95cUxQcl9ENVduUUZkUVk4MjJkRW1nQ1lydnZGNFNiYkxoUTc5RjRpaWZ2OXJKWnkyMGwyZ2JSTDhOdXVPbDA3TkhyZ1NucVd5ZFpwalotT24zdzV0Q3N1dmVQcXpxanpmRnhxamowWXV6VjRUQXJHTjJxT3VzYklaMWRmNk54dkJ6TTFqMURjbTZESEo4aDJNVzZXNEhLVjR3OE9mUkE?oc=5" target="_blank">Dyne Therapeutics(DYN.US) Director Sells US$10.71 Million in Common Stock</a>&nbsp;&nbsp;<font color="#6f6f6f">Moomoo</font>

Article excerpt provided by the FMP news feed. AI is used only for the optional "Why this matters" read.Read full article ↗
Stock Titan26 Jun 2026

Dyne Therapeutics (NASDAQ: DYN) CFO sells 2,362 shares to cover taxes - Stock Titan

<a href="https://news.google.com/rss/articles/CBMitAFBVV95cUxPNjJiRjUzUk5Ra1FyZHJNalpzUlRhV0pOc1dsSFhkVE44bjQ4MDdWbXNNbXZiVmhkUkg3T2JWVG5KdU1zXzlVMm5iUE95MDJmQnlfVmRnT01aMTR5eWQzVW9ZOVFteGVRWmNiY1Z2Y0lpdFdITC1aVUVBR2pYaXdweFBheURkWW5CWFhRdTgtUmp4SG1jQ1RWdzVVb1EwMEo5emticUxKcndDSWdtcDh6UTBBcWk?oc=5" target="_blank">Dyne Therapeutics (NASDAQ: DYN) CFO sells 2,362 shares to cover taxes</a>&nbsp;&nbsp;<font color="#6f6f6f">Stock Titan</font>

Article excerpt provided by the FMP news feed. AI is used only for the optional "Why this matters" read.Read full article ↗
Older updates drop into a lighter feed
Investing.com
17 Jun 2026
Dyne therapeutics CEO John Cox sells $49,179 in stock - Investing.com
Read ↗
Investing.com
28 May 2026
Dyne therapeutics director Brian Posner buys $36,420 in stock - Investing.com
Read ↗
Investing News Network
11 May 2026
Dyne Therapeutics Reports First Quarter 2026 Financial Results and Recent Business Highlights - Investing News Network
Read ↗
Investing News Network
8 Mar 2026
Dyne Therapeutics Announces New Positive Cardiopulmonary Results from DELIVER Trial of Z-Rostudirsen in Duchenne Muscular Dystrophy - Investing News Network
Read ↗
Quiver Quantitative
2 Mar 2026
DYNE THERAPEUTICS ($DYN) Releases Q4 2025 Earnings | DYN Stock News - Quiver Quantitative
Read ↗
Quiver Quantitative
11 Dec 2025
Dyne Therapeutics Closes $402.5 Million Upsized Public Offering of Common Stock | DYN Stock News - Quiver Quantitative
Read ↗
Earnings news

DYN earnings headlines

This section is separated from the general news feed so investors can quickly connect the latest headlines with the structured earnings report.

1
Stock Titan8 Jul 2026

Dyne Therapeutics (DYN) director-linked Atlas funds sell 777K shares under 10b5-1 plan - Stock Titan

<a href="https://news.google.com/rss/articles/CBMitAFBVV95cUxNTDN5X3AyTXZ1bmxmY2VjVDM2OG5KNHhrRmM0WUtzaFhkcExoRkNwWkozMzRkejN1alg3RjBITVpSWUM0LUZhekR1cVVyc0I1d3Fjd3k0bE1OcjM4Ukk4dXdZRzJmQ1ZKWjAwSDZWcGZGUjltMjdVekZpVjA4aUFVVDZSOGJlUXdZUDNFcGQ0UjFBdU0yc3AyMk54b2MxeUVPVU4xemZhWkxuUXlldFBId2ZVOWM?oc=5" target="_blank">Dyne Therapeutics (DYN) director-linked Atlas funds sell 777K shares under 10b5-1 plan</a>&nbsp;&nbsp;<font color="#6f6f6f">Stock Titan</font>

2
Moomoo30 Jun 2026

Dyne Therapeutics(DYN.US) Director Sells US$10.71 Million in Common Stock - Moomoo

<a href="https://news.google.com/rss/articles/CBMiogFBVV95cUxQcl9ENVduUUZkUVk4MjJkRW1nQ1lydnZGNFNiYkxoUTc5RjRpaWZ2OXJKWnkyMGwyZ2JSTDhOdXVPbDA3TkhyZ1NucVd5ZFpwalotT24zdzV0Q3N1dmVQcXpxanpmRnhxamowWXV6VjRUQXJHTjJxT3VzYklaMWRmNk54dkJ6TTFqMURjbTZESEo4aDJNVzZXNEhLVjR3OE9mUkE?oc=5" target="_blank">Dyne Therapeutics(DYN.US) Director Sells US$10.71 Million in Common Stock</a>&nbsp;&nbsp;<font color="#6f6f6f">Moomoo</font>

Beyond the headline

A deeper look for beginners

Generate a short AI read that goes beyond the headlines above, plus a plain-English breakdown of what it could mean going forward.

Continue your DYN research
Use the stock analysis page for a fuller technical read, open TradingView for charting, or head to Platforms when you are ready to place a trade.
Stock AnalysisOPEN ON TRADINGVIEW ↗TRADE THIS STOCK